Mechanism of lung fibrosis in chronic GVHD
Project/Area Number |
15H04879
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Juntendo University |
Principal Investigator |
OHNUMA Kei 順天堂大学, 医学(系)研究科(研究院), 准教授 (10396872)
|
Co-Investigator(Kenkyū-buntansha) |
森本 幾夫 順天堂大学, 医学(系)研究科(研究院), 特任教授 (30119028)
岩尾 憲明 順天堂大学, 医学部, 准教授 (00309139)
岩田 哲史 順天堂大学, 医学(系)研究科(研究院), 非常勤講師 (00396871)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2017: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2016: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2015: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Keywords | 慢性GVHD / CD26 / Caveolin-1 / IL-26 / 造血幹細胞移植 / GVHD / caveolin-1 / 線維化 / DPP4 / 移植免疫学 / 小児血液学 |
Outline of Final Research Achievements |
Obliterative bronchiolitis (OB) is the only manifestation of pulmonary chronic GVHD (cGVHD). We identified a novel effect of IL-26 on cGVHD. Humanized cGVHD mice exhibited OB with increased collagen deposition and predominant infiltration with human IL-26CD26CD4T cells. IL-26 increased collagen synthesis in fibroblasts and that collagen contents were increased in a murine GVHD model using IL26 Tg mice. IA significant increase in IL-26 production by CD4T cells following CD26 costimulation, while immunoglobulin Fc domain fused with the N-terminal of caveolin-1, the ligand for CD26, (Cav-Ig) effectively inhibited production of IL-26. Administration of Cav-Ig before or after onset of GVHD impeded the development of cGVHD without interrupting engraftment of donor-derived human cells, with preservation of the GVL effect. We concluded that cGVHD of the lungs is caused in part by IL-26CD26CD4T cells, and that treatment with Cav-Ig could be beneficial for cGVHD prevention and therapy.
|
Report
(4 results)
Research Products
(28 results)
-
-
-
-
[Journal Article] A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus2017
Author(s)
Komiya, E. Hatano, R. Otsuka, H. Itoh, T. Yamazaki, H. Yamada, T. Dang, N. H. Tominaga, M. Suga, Y. Kimura, U. Takamori, K. Morimoto, C. Ohnuma, K.
-
Journal Title
J Dermatol Sci
Volume: 印刷中
Issue: 3
Pages: 212-221
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers2017
Author(s)
Angevin, E. Isambert, N. Trillet-Lenoir, V. You, B. Alexandre, J. Zalcman, G. Vielh, P. Farace, F. Valleix, F. Podoll, T. Kuramochi, Y. Miyashita, I. Hosono, O. Dang, N. H. Ohnuma, K. Yamada, T. Kaneko, Y. Morimoto, C.
-
Journal Title
Br J Cancer
Volume: 印刷中
Issue: 9
Pages: 1-9
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Identification of senescent cell surface targetable protein DDP4.2017
Author(s)
71.Kim KM, Noh JH, Bodogai M, Martindale JL, Yang X, Indig FE, Basu SK, Ohnuma K, Morimoto C, Johnson PF, Biragyn A, Abdelmohsen K, Gorospe M.
-
Journal Title
Genes Dev
Volume: 31
Issue: 15
Pages: 1529-1534
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-